Tag: Heart Failure
Three-Drug Tx Ups Survival in Light-Chain Amyloidosis
Bortezomib, dexamethasone, alkylating agent treatment ups survival for patients with heart failure
Flu Vaccine Can Help Keep Heart Failure Patients Out of Hospital
Vaccination tied with lower risk of hospitalization for cardiovascular diseases, respiratory infections
Heart Failure Risk Up Significantly After First Myocardial Infarction
One in four MI survivors develop heart failure within four years
Two New Drugs Added to Heart Failure Clinical Practice Guideline
Heart groups issue updated guideline for the treatment of heart failure
Recent Improvement in Heart Failure Process of Care Measures
Findings for patients with acute decompensated heart failure with reduced ejection fraction, ESRD
Saxagliptin, Sitagliptin Don’t Up Hospitalized Heart Failure
No increased risk for new users of saxagliptin, sitagliptin versus other antihyperglycemic agents
Mineralocorticoid Receptor Antagonists No Benefit Post MI
MRA in addition to standard therapy does not improve outcome in setting of post-MI heart failure
Sacubitril-Valsartan May Be Cost-Effective Option in HFrEF
More costly than enalapril but more effective over a lifetime in heart failure with reduced ejection fraction
Diuretic Dose Not Linked to Outcome in Heart Failure
In multivariate analysis, no correlation seen for patients with worsening heart failure
Subclinical Cardiac Dysfunction Frequent in Hispanics/Latinos
High rate of left ventricular diastolic dysfunction; most cardiac dysfunction is subclinical, unrecognized
